FDA NDC Directory · JSON-LD · Markdown

BLUDIGO

NDC 81284-315 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameindigotindisulfonate sodium
Labeler / ManufacturerProvepharm Inc.
Marketing categoryNew Drug Application (innovator) · App NDA216264
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsINDIGOTINDISULFONATE SODIUM (8 mg/mL)
Marketing started20220906
Package count1

External sources

Source: openFDA. Public-domain (CC0).